CRNX – crinetics pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
11/15
09:00 am
crnx
Medium
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
11/14
04:17 pm
crnx
Medium
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting [Yahoo! Finance]
11/14
04:05 pm
crnx
Medium
UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
11/14
02:38 pm
crnx
Medium
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Citigroup Inc. from $70.00 to $74.00. They now have a "buy" rating on the stock.
11/14
08:02 am
crnx
Low
Crinetics Pharmaceuticals Third Quarter 2024 Earnings: US$0.96 loss per share (vs US$1.01 loss in 3Q 2023) [Yahoo! Finance]
11/12/2024
04:05 pm
CRNX
0.2%
MISS
8/8/2024
04:05 pm
CRNX
-6.1%
MISS
5/9/2024
04:05 pm
CRNX
-1.8%
MISS
2/28/2024
04:05 pm
CRNX
-4.3%
MISS
11/14
01:34 pm
Maintains
Buy
Buy
Citigroup
Low
-1.9%
11/14
01:34 pm
Maintains
Buy
Buy
Citigroup
Low
-1.9%
9/27
11:05 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
-0.4%
9/27
11:05 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
-0.4%
9/27
10:44 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
Low
-0.3%
11/14
07:56 pm
crnx
Medium
Form SC 13G/A Crinetics Pharmaceutical Filed by: Point72 Asset Management, L.P.
11/14
05:47 pm
crnx
High
Form SC 13G/A Crinetics Pharmaceutical Filed by: EcoR1 Capital, LLC
11/14
01:24 pm
crnx
Low
Form SC 13G Crinetics Pharmaceutical Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/12
04:16 pm
crnx
Low
Form 10-Q Crinetics Pharmaceutical For: Sep 30
11/12
04:08 pm
crnx
Low
Form 8-K Crinetics Pharmaceutical For: Nov 12
Show more
Top News Gainers
3/16 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 15.3%
4/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock. 11.0%
4/14 Form 424B5 Crinetics Pharmaceutical 7.6%
9/25 Crinetics Pharmaceuticals to Participate in Cantor Global Healthcare Conference 6.3%
1/8 Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 5.6%
8/7 Form 4 Crinetics Pharmaceutical For: Aug 05 Filed by: Struthers Richard Scott 5.5%
4/20 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.5%
3/4 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 4.9%
3/27 Form 3 Crinetics Pharmaceutical For: Mar 20 Filed by: Madan Ajay 4.1%
11/26 Crinetics Pharmaceuticals to Participate in the Piper Jaffray Healthcare Conference 4.1%
Top News Decliners
3/11 Form 4 Crinetics Pharmaceutical For: Mar 09 Filed by: Vivo Opportunity, LLC -14.9%
4/6 Crinetics Pharmaceuticals Reports Positive Interim Results for the ACROBAT Edge Phase 2 Trial of Paltusotine (CRN00808) in Acromegaly Patients and Provides Corporate Update -10.9%
3/9 Q4/2019 12/31/2019 EPS -0.600 ZacksConsensus -0.670 ActVsEst 0.070 - Beat -9.4%
8/13 Q2/2019 6/30/2019 EPS -0.510 ZacksConsensus N/A ActVsEst N/A - N/A -7.2%
7/29 Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH for Congenital Hyperinsulinism -5.7%
4/23 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.1%
2/25 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. -4.3%
1/11 Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating. -3.5%
2/26 Form 4 Crinetics Pharmaceutical For: Feb 24 Filed by: Struthers Richard Scott -3.2%
2/6 Form SC 13G/A Crinetics Pharmaceutical Filed by: 5AM Ventures IV, L.P. -2.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3